Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about IL-18: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No AI portrait yet
| Gene Symbol | IL |
| Full Name | 18 - Interleukin-18 |
| Chromosome | 11q22.2. |
| Function | Interleukin-1 beta (IL-1β) is a potent pro-inflammatory cytokine that plays a central role in the innate immune response and neuroinflammation. |
| GeneCards | IL |
| Human Protein Atlas | IL |
| Pro-inflammatory cytokines | TNF-α, IL-1β |
| Oxidative stress | ROS, mitochondrial dysfunction |
| Elevated levels | IL-18 is significantly elevated in CSF and plasma of AD patients compared to healthy controls |
| Disease correlation | Levels correlate with cognitive decline measured by MMSE and CDR |
| Pathology association | Associated with amyloid-β plaque deposition and tau hyperphosphorylation |
| Conversion prediction | Elevated IL-18 predicts conversion from mild cognitive impairment (MCI) to AD |
| Mechanistic role | Drives neuroinflammation and synaptic dysfunction |
| Therapeutic target | IL-18 neutralization reduces pathology in AD mouse models |
| CSF and serum elevation | Increased IL-18 in CSF and serum of PD patients |
| Associated Diseases | CRC |
| KG Connections | 1 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
IL_18(["IL-18"])
NLRP3["NLRP3"]
NLRP3_Inflammasome_Activation["NLRP3 Inflammasome Activation"]
NLRP3_Inflammasome["NLRP3 Inflammasome"]
Status_Epilepticus["Status Epilepticus"]
INFLAMMASOME["INFLAMMASOME"]
Neurodegeneration["Neurodegeneration"]
Neuroinflammation["Neuroinflammation"]
Glaucoma["Glaucoma"]
Ischemia["Ischemia"]
Neuropathy["Neuropathy"]
Inflammation["Inflammation"]
Cancer["Cancer"]
ALS["ALS"]
Parkinson["Parkinson"]
Als["Als"]
NLRP3 -->|"produces"| IL_18
NLRP3_Inflammasome_Activation -.-|"associated"| IL_18
NLRP3_Inflammasome_Activation -->|"activates"| IL_18
NLRP3_Inflammasome -.-|"associated"| IL_18
NLRP3 -->|"upstream_of"| IL_18
IL_18 -->|"biomarker_for"| Status_Epilepticus
IL_18 -->|"regulates"| INFLAMMASOME
IL_18 -->|"activates"| Neurodegeneration
IL_18 -->|"activates"| Neuroinflammation
IL_18 -->|"activates"| Glaucoma
IL_18 -->|"activates"| Ischemia
IL_18 -->|"activates"| Neuropathy
IL_18 -->|"activates"| Inflammation
IL_18 -->|"expressed in"| Cancer
IL_18 -->|"expressed in"| ALS
IL_18 -->|"activates"| Parkinson
IL_18 -.-|"associated"| Neuroinflammation
IL_18 -->|"activates"| ALS
IL_18 -.-|"associated"| Inflammation
IL_18 -->|"expressed in"| Als
style IL_18 fill:#006494,stroke:#333,color:#e0e0e0,stroke-width:2px| Target | Relation | Type | Str |
|---|---|---|---|
| Status Epilepticus | biomarker_for | disease | 0.80 |
| pyroptosis | participates_in | pathway | 0.75 |
| Parkinson | protects_against | disease | 0.65 |
| Cirrhosis | causes | disease | 0.65 |
| Inflammation | causes | disease | 0.65 |
| Alzheimer | inhibits | disease | 0.65 |
| Alzheimer | activates | disease | 0.65 |
| Alzheimer | contributes_to | disease | 0.65 |
| Als | biomarker_for | disease | 0.65 |
| Obesity | causes | disease | 0.65 |
| Hypertension | causes | disease | 0.65 |
| ALS | causes | disease | 0.65 |
| Hypertension | regulates | disease | 0.65 |
| Multiple Sclerosis | expressed_in | disease | 0.65 |
| Inflammation | associated_with | disease | 0.65 |
| INFLAMMASOME | regulates | protein | 0.65 |
| Als | regulates | disease | 0.65 |
| Obesity | regulates | disease | 0.65 |
| Als | inhibits | disease | 0.65 |
| Neuroinflammation | inhibits | disease | 0.65 |
| Neurodegeneration | biomarker_for | disease | 0.65 |
| Carcinoma | causes | disease | 0.65 |
| Epilepsy | activates | disease | 0.65 |
| Glaucoma | activates | disease | 0.65 |
| Ischemia | activates | disease | 0.65 |
| Neuropathy | activates | disease | 0.65 |
| Inflammation | activates | disease | 0.65 |
| Metabolic Syndrome | regulates | disease | 0.65 |
| Stroke | inhibits | disease | 0.65 |
| Als | expressed_in | disease | 0.65 |
| Pyroptosis | activates | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| ALS | activates | disease | 0.65 |
| Aging | activates | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Cancer | expressed_in | disease | 0.65 |
| Necroptosis | activates | disease | 0.65 |
| ALS | expressed_in | disease | 0.65 |
| Fibrosis | activates | disease | 0.65 |
| Pyroptosis | inhibits | disease | 0.65 |
| Diabetes | expressed_in | disease | 0.65 |
| Neuroinflammation | expressed_in | disease | 0.65 |
| Aging | biomarker_for | disease | 0.65 |
| Schizophrenia | biomarker_for | disease | 0.65 |
| Neurodegeneration | activates | disease | 0.65 |
| ALS | associated_with | disease | 0.65 |
| Neuroinflammation | activates | disease | 0.65 |
| Parkinson | activates | disease | 0.65 |
| Neuroinflammation | associated_with | disease | 0.65 |
| Hepatitis | causes | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| NLRP3 Inflammasome Activation | associated_with | process | 0.90 |
| NLRP3 | associated_with | protein | 0.90 |
| NLRP3 Inflammasome | associated_with | mechanism | 0.90 |
| NLRP3 Inflammasome Activation | activates | process | 0.90 |
| NLRP3 | upregulates | protein | 0.90 |
| Guhan Yangsheng Jing | downregulates | drug | 0.85 |
| GFAP | biomarker_for | gene | 0.65 |
| AMPK | transports | gene | 0.65 |
| GENES | associated_with | gene | 0.60 |
| NFKB1 | associated_with | gene | 0.60 |
| HSA-MIR-181A-5P | associated_with | gene | 0.60 |
| ALZHEIMER | contributes_to | gene | 0.60 |
| INFLAMMATION | activates | gene | 0.60 |
| INFLAMMATION | causes | gene | 0.60 |
| PER | causes | gene | 0.60 |
| TLR4 | causes | gene | 0.60 |
| TNF | causes | gene | 0.60 |
| NLRP3 | regulates | gene | 0.60 |
| GAIN | regulates | gene | 0.60 |
| AGING | activates | gene | 0.60 |
| P21 | activates | gene | 0.60 |
| PTGS2 | associated_with | gene | 0.60 |
| BCL2 | associated_with | gene | 0.60 |
| AIM2 | activates | gene | 0.60 |
| TLR9 | regulates | gene | 0.60 |
| ANGPT1 | activates | gene | 0.60 |
| PKC | protects_against | gene | 0.60 |
| CASP1 | associated_with | gene | 0.60 |
| VEGF | associated_with | gene | 0.60 |
| EPILEPSY | activates | gene | 0.60 |
| TCR | expressed_in | gene | 0.60 |
| NEURON | activates | gene | 0.60 |
| MICROGLIA | activates | gene | 0.60 |
| IL-1 | activates | gene | 0.60 |
| GLAUCOMA | activates | gene | 0.60 |
| CHAT | protects_against | gene | 0.60 |
| GFAP | protects_against | gene | 0.60 |
| BAX | associated_with | gene | 0.60 |
| NR3C1 | associated_with | gene | 0.60 |
| CD4 | expressed_in | gene | 0.60 |
| MYD88 | activates | gene | 0.60 |
| PARKINSON | activates | gene | 0.60 |
| SYK | activates | gene | 0.60 |
| JNK | activates | gene | 0.60 |
| TLR4 | regulates | gene | 0.60 |
| NLRP6 | regulates | gene | 0.60 |
| ASC | regulates | gene | 0.60 |
| FOXO3 | inhibits | gene | 0.60 |
| EXOSOMES | inhibits | gene | 0.60 |
| STROKE | inhibits | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning IL-18 in their description or question text
No additional research found